Erratum to: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors

被引：0
|
作者：
Karin Oechsle
Carsten Bokemeyer
Friedemann Honecker
机构：
[1] University Medical Center Eppendorf,Departments of Oncology, Hematology, Bone Marrow Transplantation and Pneumology
来源：
Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷 / 1期
关键词：
D O I：
10.1007/s00432-009-0697-y
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
    C Kollmannsberger
    O Rick
    H Klaproth
    T Kubin
    H G Sayer
    M Hentrich
    M Welslau
    F Mayer
    M Kuczyk
    C Spott
    L Kanz
    C Bokemeyer
    British Journal of Cancer, 2002, 87 : 729 - 732
  • [32] Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
    Kollmannsberger, C
    Rick, O
    Klaproth, H
    Kubin, T
    Sayer, HG
    Hentrich, M
    Welslau, M
    Mayer, F
    Kuczyk, M
    Spott, C
    Kanz, L
    Bokemeyer, C
    BRITISH JOURNAL OF CANCER, 2002, 87 (07) : 729 - 732
  • [33] Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
    Powles, T
    Shamash, J
    Berney, D
    Oliver, RTD
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 1140 - 1141
  • [34] Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
    T Powles
    J Shamash
    D Berney
    R T D Oliver
    British Journal of Cancer, 2003, 89 : 1140 - 1141
  • [35] Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
    C Kollmannsberger
    C Bokemeyer
    British Journal of Cancer, 2003, 89 : 1141 - 1142
  • [36] Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
    Kollmannsberger, C
    Bokemeyer, C
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 1141 - 1142
  • [37] Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients
    P. Soulié
    C. Garrino
    M. A. Bensmaïne
    M. Bekradda
    E. Brain
    M. Di Palma
    A. Goupil
    J. L. Misset
    E. Cvitkovic
    Journal of Cancer Research and Clinical Oncology, 1999, 125 : 707 - 711
  • [38] Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients
    Soulié, P
    Garrino, C
    Bensamaïne, MA
    Bekradda, M
    Brain, E
    Di Palma, M
    Goupil, A
    Misset, JL
    Cvitkovic, E
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (12) : 707 - 711
  • [39] Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
    Bokemeyer, C
    Beyer, J
    Metzner, B
    Ruther, U
    Harstrick, A
    Weissbach, L
    Kohrmann, U
    Verbeek, W
    Schmoll, HJ
    ANNALS OF ONCOLOGY, 1996, 7 (01) : 31 - 34
  • [40] Cisplatin-refractory germ cell tumours-molecular background and clinical concepts
    Bokemeyer, Carsten
    Skowron, Margaretha A.
    Peters, Mia-Carlotta
    Nettersheim, Daniel
    Oing, Christoph
    ONKOLOGE, 2021, 27 (01): : 46 - 53
12345